$2.38 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest



Nemaura Medical Inc. is a medical technology company. The Company is focused on developing sugarBEAT, which is a non-invasive, glucose monitoring system, for use by persons with Type I and Type II diabetes and used to screen pre-diabetic patients. SugarBEAT consists of disposable adhesive skin-patch containing a sensor, which is connected to a rechargeable wireless transmitter.The SugarBEAT works by extracting glucose from the skin into a chamber in the patch that is in direct contact with an electrode-based sensor .The sensor takes a measurement of the glucose reading every five minutes and sends the data by low energy blue tooth to a smart device such as mobile phone (both android and iOS).The data is recorded on the app and can be viewed in real time as well as storing all historic data for later evaluation as desired. The Company's subsidiaries include Region Green Limited.

Stock Analysis

last close $2.38
1-mo return 25.9%
3-mo return -18%
avg daily vol. 10.26T
52-week high 7.88
52-week low 1.7
market cap. $58M
forward pe -
annual div. -
roe -315%
ltg forecast -
dividend yield -
annual rev. $1M
inst own. 3.7%

Subscribe now for daily local and international financial news